PRESS RELEASE published on 05/30/2024 at 15:01, 1 year 9 months ago Press Release: Sanofi completes acquisition of Inhibrx, Inc. Sanofi completes acquisition of Inhibrx, Inc., adding SAR447537 to rare disease pipeline. Former Inhibrx shareholders receive $30.00 per share in cash and one contingent value right. Inhibrx Biosciences begins trading on NASDAQ as INXB Acquisition Nasdaq Sanofi Inhibrx SAR447537
BRIEF published on 05/27/2024 at 07:05, 1 year 9 months ago FDA Grants Priority Review to Sarclisa for Treatment of Multiple Myeloma FDA Sanofi Multiple Myeloma Sarclisa Chemotherapy
BRIEF published on 05/21/2024 at 07:35, 1 year 9 months ago Sanofi, Formation Bio, and OpenAI Announce AI Collaboration Collaboration AI Drug Development Sanofi OpenAI Formation Bio
PRESS RELEASE published on 05/21/2024 at 07:30, 1 year 9 months ago Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Sanofi, Formation Bio, and OpenAI collaborate to accelerate drug development with AI-powered software. The partnership aims to bring new medicines more efficiently Collaboration Drug Development Sanofi OpenAI Formation Bio
BRIEF published on 05/20/2024 at 22:59, 1 year 9 months ago Sanofi: April 2024 Voting Rights and Shares Information Voting Rights Shares Financial Disclosure April 2024 Sanofi
PRESS RELEASE published on 05/20/2024 at 22:54, 1 year 9 months ago Sanofi: Information concerning the total number of voting rights and shares - April 2024 Sanofi provides total number of issued shares and voting rights as per French Commercial Code and AMF regulations for April 30, 2024 Share Capital Voting Rights French Commercial Code AMF Regulations Sanofi
BRIEF published on 05/20/2024 at 20:20, 1 year 9 months ago Dupixent® Reduces COPD Exacerbations in Phase III Study FDA Clinical Study Inflammation COPD Dupixent
PRESS RELEASE published on 05/20/2024 at 20:15, 1 year 9 months ago Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM Late-breaking data from NOTUS confirm Dupixent's effectiveness in reducing COPD exacerbations and improving lung function, presented at ATS and published in NEJM COPD Dupixent NOTUS Lung Function Exacerbations
BRIEF published on 05/10/2024 at 08:05, 1 year 10 months ago Sanofi and Novavax Form Strategic Alliance to Enhance Vaccine Accessibility COVID-19 Vaccine Vaccine Development Sanofi Novavax Flu Vaccine
PRESS RELEASE published on 05/10/2024 at 08:00, 1 year 10 months ago Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Sanofi and Novavax sign co-exclusive licensing agreement to co-commercialize COVID-19 vaccine & develop flu-COVID-19 combo vaccines. Agreement enhances patient access & protection. Details in press release COVID-19 Vaccine Licensing Agreement Sanofi Novavax Flu-COVID-19
Published on 03/17/2026 at 13:30, 6 hours 51 minutes ago Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026
Published on 03/17/2026 at 13:30, 6 hours 51 minutes ago Namibia Critical Metals Welcomes Toyota Tsusho as Strategic Partner in the Lofdal Heavy Rare Earths Project
Published on 03/17/2026 at 13:00, 7 hours 21 minutes ago Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland
Published on 03/17/2026 at 13:00, 7 hours 21 minutes ago High-Resolution Airborne Survey Completed at Music Valley HREE Project
Published on 03/17/2026 at 12:30, 7 hours 51 minutes ago Revival Gold Targets Underground Resource Growth With Drilling at Beartrack-Arnett Gold Project in Idaho
Published on 03/17/2026 at 17:58, 2 hours 23 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/17/2026 at 15:30, 4 hours 51 minutes ago Original-Research: Desert Gold Ventures Inc. (von GBC AG): Buy
Published on 03/17/2026 at 15:19, 5 hours 2 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 03/17/2026 at 07:00, 13 hours 21 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day 2 hours ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day 2 hours ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day 2 hours ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026